Oxford Biomedica plc (LON: OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
425.00
-1.50 (-0.35%)
Dec 23, 2024, 4:35 PM BST

Oxford Biomedica Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4522134261,059848496
Upgrade
Market Cap Growth
-23.01%-50.00%-59.79%24.98%71.01%6.05%
Upgrade
Enterprise Value
4862234531,008808478
Upgrade
Last Close Price
4.262.204.4212.3010.306.45
Upgrade
PE Ratio
---55.72--
Upgrade
Forward PE
---60.29--
Upgrade
PS Ratio
4.422.383.047.429.667.74
Upgrade
PB Ratio
6.782.741.805.657.526.55
Upgrade
P/TBV Ratio
8.614.954.315.667.526.56
Upgrade
P/FCF Ratio
---66.23--
Upgrade
P/OCF Ratio
---41.62272.03-
Upgrade
EV/Sales Ratio
4.992.493.247.069.217.46
Upgrade
EV/EBITDA Ratio
---30.85224.65-
Upgrade
EV/EBIT Ratio
---45.53--
Upgrade
EV/FCF Ratio
-6.74--63.01--
Upgrade
Debt / Equity Ratio
1.551.430.480.050.120.11
Upgrade
Debt / EBITDA Ratio
---0.272.78-
Upgrade
Debt / FCF Ratio
---0.58--
Upgrade
Asset Turnover
0.300.250.400.680.570.54
Upgrade
Inventory Turnover
4.093.916.397.328.7810.46
Upgrade
Quick Ratio
1.992.803.334.541.881.82
Upgrade
Current Ratio
2.353.193.614.922.061.97
Upgrade
Return on Equity (ROE)
-124.66%-117.29%-21.32%12.67%-6.63%-29.11%
Upgrade
Return on Assets (ROA)
-12.67%-15.08%-8.33%6.57%-1.98%-6.68%
Upgrade
Return on Capital (ROIC)
-16.61%-19.91%-10.61%8.56%-2.89%-9.84%
Upgrade
Earnings Yield
-45.50%-73.95%-9.19%1.79%-0.74%-3.24%
Upgrade
FCF Yield
-23.10%-18.01%-6.79%1.51%-1.21%-5.91%
Upgrade
Buyback Yield / Dilution
-4.65%-1.82%-10.76%-7.10%-9.95%-5.01%
Upgrade
Total Shareholder Return
-4.65%-1.82%-10.76%-7.10%-9.95%-5.01%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.